This inventor holds 1 USPTO granted patent. Top assignees: Jiangxi Leyun Health Technology Co., Ltd, The First Affiliated Hospital of Guangzhou Medical University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2026
Title: Mingshu Mo: Innovator in Neurodegenerative Disease Treatment
Introduction
Mingshu Mo is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of medical technology, particularly in the treatment of neurodegenerative diseases. His innovative approach has garnered attention in the medical community.
Latest Patents
Mingshu Mo holds a patent for a "Modified Hemofiltration Method for Clearing Peripheral α-synuclein Aggregates in Patients with Neurodegenerative Disease." This patent represents a crucial advancement in the treatment of conditions such as Parkinson's disease, where α-synuclein aggregation is a key factor.
Career Highlights
Throughout his career, Mingshu Mo has worked with notable institutions, including the First Affiliated Hospital of Guangzhou Medical University and Jiangxi Leyun Health Technology Co., Ltd. His work in these organizations has allowed him to develop and refine his innovative methods for treating neurodegenerative diseases.
Collaborations
Mingshu Mo has collaborated with esteemed colleagues, including Lin Lu and Yangfu Luo. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the medical field.
Conclusion
Mingshu Mo's contributions to the treatment of neurodegenerative diseases through his patented methods highlight his role as an influential inventor. His dedication to innovation continues to inspire advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile